The new approach focuses on long-term skin performance and sustained outcomes, moving away from single treatments.
Alma, a Sisram Medical company, unveiled its new longevity strategy at its global Alma Academy event, announcing a shift toward a continuous care model for medical aesthetics.
The company outlined its transition to a platform designed for ongoing, outcomes-driven care. According to a company release, this approach reflects a change in patient expectations, with a growing priority on prevention, long-term results, and personalized experiences. Alma’s longevity strategy centers on enhancing skin function and quality over time, starting earlier, by using an integrated ecosystem of technologies intended to activate the skin’s natural regenerative and adaptive responses.
“Longevity is redefining aesthetics as a discipline of performance over time,” says Eyal Ben David, CEO of Alma, in a release. “The focus is on enhancing how skin functions, adapts, and maintains quality, through controlled biological responses that drive regeneration, resilience, and structural improvement. This approach enables practitioners to deliver measurable, sustained outcomes and build long-term value through consistent skin performance.”
Insights from the Global Summit
The announcement was made before an audience of 430 physicians from 45 countries. The summit featured 19 speakers, including Dr Spero Theodorou, Prof Ofir Artzi, Dr Pablo Naranjo, Dr Tino Solomon, and Dr Jaerim Kim.
Sessions covered key clinical indications such as skin rejuvenation, vascular indications, acne and acne scars, pigmentation, skin laxity, scars, and the treatment of challenging skin conditions.
Photo caption: Panelists speak before the audience at Alma Academy.
Photo credit: Alma
